Australia is evaluating the impact of potential US tariffs of 200% on pharmaceutical imports, Treasurer Jim Chalmers said, while reiterating that his nation’s subsidies for certain drugs are not up ...

Johnson & Johnson (J&J) has halved its expectations for costs this year related to new tariffs and raised its full-year sales ...

Conversations with the Trump administration on its “most favored nation” policy have been productive, the executive said ...

In its Q2 earnings call Thursday, Novartis said it is moving quickly to reshore its drug manufacturing operations, but CEO ...

U.S. President Donald Trump has announced that China may soon implement the death penalty for those involved in fentanyl ...

Early trading on Wall Street was quietly mixed as markets shift their attention toward a deluge of corporate earnings reports ...

President Donald Trump says it is “highly unlikely” he will fire Federal Reserve Chairman Jerome Powell “unless he has to ...

Shares of Johnson & Johnson climbed 6.8% in morning trading, enough to pace the S&P 500 index's SPX gainers. They were also headed for their biggest one-day gain and best postearnings reaction since ...

Johnson & Johnson shares jumped to their highest price in more than three months as the US-based healthcare group shrugged ...

President Donald Trump will welcome Bahrain Crown Prince Salman bin Hamad Al Khalifa to the White House on Wednesday. It’s ...

Johnson & Johnson halved its expectations for costs this year related to new tariffs and raised its full-year sales and ...

President Trump has flagged that US tariffs on pharmaceutical imports are likely to kick in on Aug. 1, with duties on ...